生物资讯服务市场规模、份额和成长分析（按类型、应用、产业、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，生物资讯服务市场规模将达到 38.9 亿美元，到 2025 年将成长至 45.1 亿美元，到 2033 年将成长至 147 亿美元，在预测期（2026-2033 年）内，复合年增长率为 15.9%。

受个人化医疗需求成长以及基因组学和蛋白​​质组学研究进展的推动，生物资讯服务市场正经历显着扩张。次世代定序技术产生的基因组数据呈现爆炸性成长，因此需要高效率的管理和解读，进而推动了对生物资讯服务的需求。人工智慧和机器学习的融合增强了市场动态，促进了预测建模和药物发现的进步。此外，云端运算在资料储存和分析领域的应用，以及对资料标准化和互通性的重视，也推动了市场成长。新兴市场受惠于政府的支持性政策和对生物资讯学基础设施的投资。整体而言，资讯和通讯技术的进步有望刺激研发活动，进一步推动该领域的市场发展。

生物资讯服务市场驱动因素

个人化医疗（根据个人的基因谱和独特特征量身定制医疗保健解决方案）日益受到关注，这正显着影响着生物资讯服务市场。这些服务对于分析和解读基因组数据至关重要，能够识别生物标记、评估疾病风险并优化治疗策略。随着个人化医疗需求的不断增长，生物资讯服务在研究和临床领域的应用也日益广泛，凸显了这些服务在改善医疗效果和提高整体医疗服务效率方面发挥的关键作用。

生物资讯服务市场的限制因素

由于生物资讯服务市场依赖大量的基因组和蛋白质组数据，因此面临许多挑战。生物数据的复杂性和变异性阻碍了标准化、无缝整合和严格品管的实现。不完整或不一致的数据会导致结果不准确，并妨碍对生物过程的准确解读。反过来，这会对生物资讯服务的效率和可靠性产生负面影响，最终限制其在生命科学研究和应用领域中发挥潜在作用和发挥效力。应对这些挑战对于该领域的持续发展和成功至关重要。

生物资讯服务市场的发展趋势

生物资讯服务市场正经历着向云端解决方案的重大转型，其特点是对可扩展性、成本效益和增强协作能力的需求日益增长。研究人员和机构越来越多地采用云端平台进行资料储存、分析和共用，有效缓解了传统本地部署基础设施带来的挑战。这一趋势透过提供灵活的运算资源存取和促进跨地域协作，推动了创新并加速了研究成果的产出。随着生物数据量的持续飙升，云端运算已成为生物资讯领域不可或缺的工具，有望推动该领域的成长并革新调查方法。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

全球生物资讯服务市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 定序服务
• 数据分析
• 药物发现服务
• 差异基因表现分析
• 资料库和管理服务
• 其他生物资讯服务

全球生物资讯服务市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 基因组学
  • 功能基因体学
  • 结构基因体学
  • 比较基因组学
• 化学资讯学与药物设计
• 蛋白质体学
  • 蛋白质鑑定
  • 蛋白质结构预测
• 转录组学
• 代谢体学
• 其他的

全球生物资讯服务市场规模（按产业划分）及复合年增长率（2026-2033 年）

• 医疗保健
  • 临床诊断
  • 药物发现与开发
• 动物
  • 兽医诊断
  • 畜牧养殖
• 农业
  • 作物改良
  • 有害生物防治
• 学术的
  • 研究计划
  • 教育计划

全球生物资讯服务市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 学术机构与研究中心
• 医院和诊所
• 製药和生物技术公司
• CRO
• 其他的

全球生物资讯服务市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Illumina, Inc.（USA）
• QIAGEN（Germany）
• Thermo Fisher Scientific Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• BGI Group（China）
• IBM Life Sciences（USA）
• Waters Corporation（USA）
• Partek Incorporated（USA）
• Biomatters Ltd.（New Zealand）
• Macrogen, Inc.（South Korea）
• DNASTAR, Inc.（USA）
• GenoSpace（USA）
• Nonlinear Dynamics Ltd.（UK）
• Molecular Connections Pvt. Ltd.（India）
• Eagle Genomics Ltd.（UK）
• SOPHiA GENETICS（Switzerland）
• Seven Bridges Genomics（USA）
• InSilixa Inc.（USA）

结论与建议

Bioinformatics Services Market size was valued at USD 3.89 Billion in 2024 and is poised to grow from USD 4.51 Billion in 2025 to USD 14.7 Billion by 2033, growing at a CAGR of 15.9% during the forecast period (2026-2033).

The bioinformatics services market is experiencing significant expansion, driven by a rising demand for personalized medicine and advancements in genomics and proteomics research. The surge in genomic data from next-generation sequencing technologies necessitates efficient management and interpretation, increasing the need for bioinformatics services. The incorporation of AI and machine learning is enhancing market dynamics, facilitating advancements in predictive modeling and drug discovery. Additionally, the adoption of cloud computing for data storage and analytics is fostering growth, alongside the emphasis on data standardization and interoperability. Emerging markets are benefiting from supportive government policies and investments in bioinformatics infrastructure. Overall, improvements in information and communication technology are anticipated to stimulate R&D efforts, further propelling market development in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioinformatics Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioinformatics Services Market Segments Analysis

Global Bioinformatics Services Market is segmented by type, application, sector, end user and region. Based on type, the market is segmented into sequencing services, data analysis, drug discovery services, differential gene expression analysis, database and management services and other bioinformatics services. Based on application, the market is segmented into genomics, cheminformatics & drug design, proteomics, transcriptomics, metabolomics and others. Based on sector, the market is segmented into medical, animal, agricultural and academics. Based on end user, the market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, Cros and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioinformatics Services Market

The increasing focus on personalized medicine, which seeks to deliver customized healthcare solutions tailored to an individual's genetic profile and distinct characteristics, is significantly influencing the Bioinformatics Services market. These services are essential for the analysis and interpretation of genomic data, enabling the identification of biomarkers, assessing disease risk, and refining treatment strategies. As the need for personalized healthcare continues to escalate, the adoption of bioinformatics services in research and clinical environments is also on the rise, highlighting their pivotal role in advancing medical outcomes and enhancing the overall effectiveness of healthcare delivery.

Restraints in the Bioinformatics Services Market

The Bioinformatics Services market faces significant challenges due to its dependence on extensive genomic and proteomic data. The intricate nature and variability of biological data create obstacles in achieving standardization, seamless integration, and stringent quality control. When data is incomplete or inconsistent, it can result in inaccurate findings and hinder the precise interpretation of biological processes. This, in turn, adversely affects the efficiency and reliability of bioinformatics services, ultimately limiting their potential impact and effectiveness in advancing research and applications in the life sciences. Addressing these issues is crucial for the continued growth and success of the sector.

Market Trends of the Bioinformatics Services Market

The bioinformatics services market is witnessing a significant shift towards cloud-based solutions, characterized by an increasing demand for scalability, cost-efficiency, and enhanced collaborative capabilities. Researchers and organizations are increasingly adopting cloud platforms for data storage, analysis, and sharing, which effectively mitigate the challenges posed by traditional on-premises infrastructures. This trend is fostering innovation and accelerating research outcomes, as it allows for more flexible access to computational resources and facilitates collaboration across geographic boundaries. As the volume of biological data continues to surge, cloud computing is poised to become an indispensable tool in the bioinformatics landscape, driving growth and modernizing research methodologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Bioinformatics Services Market Size by Type & CAGR (2026-2033)

• Market Overview
• Sequencing Services
• Data Analysis
• Drug Discovery Services
• Differential Gene Expression Analysis
• Database And Management Services
• Other Bioinformatics Services

Global Bioinformatics Services Market Size by Application & CAGR (2026-2033)

• Market Overview
• Genomics
  • Functional Genomics
  • Structural Genomics
  • Comparative Genomics
• Cheminformatics & Drug Design
• Proteomics
  • Protein Identification
  • Protein Structure Prediction
• Transcriptomics
• Metabolomics
• Others

Global Bioinformatics Services Market Size by Sector & CAGR (2026-2033)

• Market Overview
• Medical
  • Clinical Diagnostics
  • Drug Discovery & Development
• Animal
  • Veterinary Diagnostics
  • Animal Breeding
• Agricultural
  • Crop Improvement
  • Pest Control
• Academics
  • Research Projects
  • Educational Programs

Global Bioinformatics Services Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic Institutes & Research Centers
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Cros
• Other

Global Bioinformatics Services Market Size & CAGR (2026-2033)

• North America (Type, Application, Sector, End User)
  • USA
  • Canada
• Europe (Type, Application, Sector, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Sector, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Sector, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Sector, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Partek Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomatters Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNASTAR, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenoSpace (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nonlinear Dynamics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Connections Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eagle Genomics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOPHiA GENETICS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSilixa Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations